Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccination
Anika M. Valk, Jim B.D. Keijser, Koos P.J. van Dam, Eileen W. Stalman, View ORCID ProfileLuuk Wieske, Maurice Steenhuis, Laura Y.L. Kummer, Phyllis I. Spuls, Marcel W. Bekkenk, Annelie H. Musters, Nicoline F. Post, Angela L. Bosma, Barbara Horváth, DirkJan Hijnen, Corine R.G. Schreurs, Zoé L.E. van Kempen, View ORCID ProfileJoep Killestein, Adriaan G. Volkers, Sander W. Tas, Laura Boekel, View ORCID ProfileGerrit J. Wolbink, Sofie Keijzer, Ninotska I.L. Derksen, Melanie van Deelen, Gerard van Mierlo, View ORCID ProfileTaco W. Kuijpers, Filip Eftimov, S. Marieke van Ham, View ORCID ProfileAnja ten Brinke, View ORCID ProfileTheo Rispens, T2B! Immunity against SARS-CoV-2 study group
doi: https://doi.org/10.1101/2023.09.29.23296354
Anika M. Valk
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
2Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, the Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
MSc, LLBJim B.D. Keijser
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
MScKoos P.J. van Dam
4Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
MDEileen W. Stalman
4Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
MDLuuk Wieske
4Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
5Department of Clinical Neurophysiology, St Antonius Hospital, Nieuwegein, The Netherlands
MD, PhDMaurice Steenhuis
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
PhDLaura Y.L. Kummer
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
4Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
MDPhyllis I. Spuls
6Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, the Netherlands
MD, PhDMarcel W. Bekkenk
6Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, the Netherlands
MD, PhDAnnelie H. Musters
6Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, the Netherlands
MDNicoline F. Post
6Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, the Netherlands
MDAngela L. Bosma
6Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, the Netherlands
MDBarbara Horváth
7Department of Dermatology, UMCG Expertise Center for Blistering Diseases, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
MD, PhDDirkJan Hijnen
8Department of Dermatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands
MD, PhDCorine R.G. Schreurs
8Department of Dermatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands
MDZoé L.E. van Kempen
9Department of Neurology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands
MD, PhDJoep Killestein
9Department of Neurology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands
MD, PhDAdriaan G. Volkers
10Department of Gastroenterology and Hepatology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
MDSander W. Tas
11Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
MD, PhDLaura Boekel
12Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, the Netherlands
BScGerrit J. Wolbink
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
12Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, the Netherlands
MD, PhDSofie Keijzer
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
MScNinotska I.L. Derksen
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
MScMelanie van Deelen
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
BScGerard van Mierlo
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Taco W. Kuijpers
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
13Department of Pediatric Immunology, Rheumatology and Infectious Disease, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
MD, PhDFilip Eftimov
4Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
MD, PhDS. Marieke van Ham
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
2Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, the Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
PhDAnja ten Brinke
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
PhDTheo Rispens
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands
3Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
PhD
Data Availability
All data produced in the present work are contained in the manuscript
Posted October 02, 2023.
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccination
Anika M. Valk, Jim B.D. Keijser, Koos P.J. van Dam, Eileen W. Stalman, Luuk Wieske, Maurice Steenhuis, Laura Y.L. Kummer, Phyllis I. Spuls, Marcel W. Bekkenk, Annelie H. Musters, Nicoline F. Post, Angela L. Bosma, Barbara Horváth, DirkJan Hijnen, Corine R.G. Schreurs, Zoé L.E. van Kempen, Joep Killestein, Adriaan G. Volkers, Sander W. Tas, Laura Boekel, Gerrit J. Wolbink, Sofie Keijzer, Ninotska I.L. Derksen, Melanie van Deelen, Gerard van Mierlo, Taco W. Kuijpers, Filip Eftimov, S. Marieke van Ham, Anja ten Brinke, Theo Rispens, T2B! Immunity against SARS-CoV-2 study group
medRxiv 2023.09.29.23296354; doi: https://doi.org/10.1101/2023.09.29.23296354
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccination
Anika M. Valk, Jim B.D. Keijser, Koos P.J. van Dam, Eileen W. Stalman, Luuk Wieske, Maurice Steenhuis, Laura Y.L. Kummer, Phyllis I. Spuls, Marcel W. Bekkenk, Annelie H. Musters, Nicoline F. Post, Angela L. Bosma, Barbara Horváth, DirkJan Hijnen, Corine R.G. Schreurs, Zoé L.E. van Kempen, Joep Killestein, Adriaan G. Volkers, Sander W. Tas, Laura Boekel, Gerrit J. Wolbink, Sofie Keijzer, Ninotska I.L. Derksen, Melanie van Deelen, Gerard van Mierlo, Taco W. Kuijpers, Filip Eftimov, S. Marieke van Ham, Anja ten Brinke, Theo Rispens, T2B! Immunity against SARS-CoV-2 study group
medRxiv 2023.09.29.23296354; doi: https://doi.org/10.1101/2023.09.29.23296354
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)